- Sarepta tumbles as its gene therapy sales decline further<figure><div><img src="https://imgproxy.divecdn.com/XaTqfcte0RAZt6-RIcgWQ5i2KmL-mKKasPXR8xjfQW8/g:nowe:0:858/c:4256:2405/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TYXJlcHRhX0Jvc…BioPharma Dive · 2mo ago↗ source
- Angelini to buy Catalyst in $4B play for rare neuro drugs<figure><div><img src="https://imgproxy.divecdn.com/4_eQ3BQP0sHe3AjR5s7bySznoaDhyqMpmhkmNubOdkU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDQwMTY4MDMyXzEua…BioPharma Dive · 2mo ago↗ source
- Entrada shares dive as Duchenne results disappoint<figure><div><img src="https://imgproxy.divecdn.com/xa_T0oT9Hj8F-wJjKfJeFkbn4Yqp_lT58dL0S4GszxY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02MjEzNjQ4MDJfMS5qc…